Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02522442 · ClinicalTrials.gov registry record · NA
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02522442 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 51 participants.
The verdict
NCT02522442, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The primary objective outcome is the proportion of participants compliant (at least four hours of use per night for all nights) in the Auto Bilevel group compared to the continuous positive airway pressure (CPAP) group after 90 days of treatment during the investigation. Proportion will be calculated using the cumulative number of hours on therapy divided by the total number of days of the investigation for each participant. The mean and standard deviation of these mean therapy hours will then be calculated for each arm of the investigation. Participants with compliance of at least four hours will be classified as "compliant" and those with less than four hours will be classified as "non-compliant". The null hypothesis will be rejected if the mean of the primary objective outcome for all participants in the BiPAP® Auto with Bi-Flex® therapy (auto Bilevel) arm is significantly greater than that for all participants in the CPAP therapy arm
Interventions
- DEVICE CPAP
- DEVICE Auto BiLevel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02522442
The ClinicalTrials.gov registry entry for NCT02522442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPAP is the first listed.
NCT02522442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02522442 about?
NCT02522442 is a clinical study titled "Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)". The primary objective outcome is the proportion of participants compliant (at least four hours of use per night for all nights) in the Auto Bilevel group compared to the continuous positive airway pressure (CPAP) group after 90 days of treatment during the investigation. Proportion will be calculate...
What is the current status of trial NCT02522442?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2007-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT02522442?
The interventions under investigation include: CPAP (DEVICE), Auto BiLevel (DEVICE).
Who is sponsoring clinical trial NCT02522442?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.